Komori
Fuso Pharmaceutical Industries (4538) · FactUpdated the full-year loss from operation of investment partnerships

Recognition of Gains on Investment Limited Partnership Operations

First written in FY2022-Q3. . Latest entry: FY2023.

6entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2022-Q3 – FY20232022: 420222023: 22023
Same theme, other companies
Recognition of Gains on Investment Limited Partnership OperationsA theme 17 companies write about · 3 as a headwind · 10 as a tailwind

The whole theme swung hardest in 2026: 4 of 9 companies on the "Worse" side.

4 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 17 companies compared. The sentences above are computed from all 17.
Full recordFilings, disclosures and news, newest first
  1. FY2023Updated the full-year loss from operation of investment partnershipsAnnual report

    「Income (loss) from operation of investment partnerships (△ indicates income) △ 67 3」

    The Company recorded ¥3 million in income (loss) from operation of investment partnerships for FY2023, a change from the ¥67 million in income from operation of investment partnerships recorded in the previous year.
  2. FY2023-Q3Updated the income from operation of investment partnerships for the cumulative period of the third quarterAnnual report

    「Income from operation of investment partnerships 68 -」

    No income from operation of investment partnerships was recorded during the cumulative period of the third quarter, down from ¥68 million in the same period of the previous year.
  3. FY2023-Q2Updated the first-half income from operation of investment partnershipsAnnual report

    「Income from operation of investment partnerships 69 1」

    Income from operation of investment partnerships was ¥1 million during the cumulative period of the second quarter of the current fiscal year, down from ¥69 million in the same period of the previous year.
  4. FY2023-Q1Updated the first-quarter income from operation of investment partnershipsAnnual report

    「Income from operation of investment partnerships 69 0」

    Income from operation of investment partnerships was ¥0 million during the cumulative period of the first quarter of the current fiscal year, down from ¥69 million in the same period of the previous year.
  5. FY2022Updated the full-year income from operation of investment partnershipsAnnual report

    「Income (loss) from operation of investment partnerships (△ indicates income) △67」

    The FY2022 full-year statement of cash flows records ¥67 million in income from operation of investment partnerships.
  6. FY2022-Q3First statedAnnual report

    「Income from operation of investment partnerships - 68」

    The Company recorded income from operation of investment partnerships of ¥68 million as non-operating income during the cumulative period of the third quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuso Pharmaceutical Industries yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.